Setting the Stage for AI in the Pharma Cold Chain
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
Pharma Technology
The Future of Pharma: Technology for a more Predictable and Secure Medication Landscape
The pharmaceutical industry plays a vital role in safeguarding public health. However, in recent years the public have played witness to a concerning rise in…
Transforming Rebate Contract Management in Pharmaceuticals: The AI Advantage
In the pharmaceutical industry, many rebate contract managers spend hundreds of hours manually identifying key data points from thousands of contracts. Rebate contracts can impact…
Early, Built-in GxP System Validation: A Critical Determinant of Project Success
As Life Sciences companies comes to rely increasingly on digital capabilities and good data for efficiency and competitive advantage, it’s critical that they harness system…
Could GenAI Revolutionise Pharma Medical Writing?
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Patients Are Waiting: Speeding Time to Treatment in Rare Disease
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
Current State of Drug Development, Clinical Trials, and Precision Measures
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
What’s the State of AI-enabled Automation in Pharma R&D?
Smart automation promises to transform life sciences research and development operations, and streamline pharma companies’ path to market while enhancing patient safety. But how far…
3PARL Consortium to Assure Global Life Sciences Industry of High Standard of GMP Supply Chain Audits
The new Third-Party Audit Report Library (3PARL®) consortium, founded by Rephine and Eurofins Healthcare, aims to set a benchmark for life sciences manufacturing supply chain…
Unlocking the Advantages of eCTD 4.0 Compliance
The long-awaited eCTD 4.0 standard is now available, though it is not yet mandatory. Life sciences companies can tap into the detail of the standard…